Evaluating the Effect of Underlying Pulmonary Disease on the Clinical Outcome and survival among Patients with COVID-19: Using Propensity Score Matching
暂无分享,去创建一个
J. Faradmal | G. Roshanaei | S. Bashirian | Malihe Safari | Fatemeh Ghadamgahi | A. Soltanian | Salman Khazaei
[1] N. Motoc,et al. Prognosis Predictive Markers in Patients with Chronic Obstructive Pulmonary Disease and COVID-19 , 2023, Diagnostics.
[2] Nikhil T. Awatade,et al. The Complex Association between COPD and COVID-19 , 2023, Journal of clinical medicine.
[3] G. Guaraldi,et al. Drug treatment of COVID-19 infection , 2023, Current opinion in pulmonary medicine.
[4] M. Falcone,et al. Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience , 2022, Infectious Diseases and Therapy.
[5] R. Flisiak,et al. Oral antiviral treatments for COVID-19: opportunities and challenges , 2022, Pharmacological Reports.
[6] C. Schooling,et al. Association of smoking, lung function and COPD in COVID‐19 risk: a two‐step Mendelian randomization study , 2022, Addiction.
[7] J. Butterton,et al. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients , 2021, The New England journal of medicine.
[8] G. Roshanaei,et al. The effect of underlying diabetes disease on clinical outcome and survival in patients with Covid-19: a propensity score matching study , 2021, Journal of Diabetes & Metabolic Disorders.
[9] W. Guan,et al. Impact of Chronic Respiratory Diseases on the Outcomes of COVID-19 , 2021, Archivos de Bronconeumología.
[10] P. Koul,et al. The impact of COVID-19 on patients with preexisting interstitial lung disease: High mortality in these high-risk patients , 2021, Lung India : official organ of Indian Chest Society.
[11] D. Neuberg,et al. Intermediate‐dose anticoagulation, aspirin, and in‐hospital mortality in COVID‐19: A propensity score‐matched analysis , 2021, American journal of hematology.
[12] Yu Wang,et al. Risk factors of mortality and contribution of treatment in patients infected with COVID-19: a retrospective propensity score matched study , 2020, Current medical research and opinion.
[13] B. Morrison,et al. Endothelial Cell Contributions to COVID-19 , 2020, Pathogens.
[14] S. El-Chemaly,et al. Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case–Control Study , 2020, American journal of respiratory and critical care medicine.
[15] P. Peng,et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2 , 2020, European Respiratory Journal.
[16] Sang Woo Park,et al. Potential Role of Social Distancing in Mitigating Spread of Coronavirus Disease, South Korea , 2020, Emerging infectious diseases.
[17] Jordan J. Clark,et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score , 2020, BMJ.
[18] D. Ma,et al. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis , 2020, Journal of Hematology & Oncology.
[19] Jiaofeng Huang,et al. The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis , 2020, Journal of medical virology.
[20] Jing Shi,et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan , 2020, Journal of Allergy and Clinical Immunology.
[21] A. Desai,et al. COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis. , 2020, JCO global oncology.
[22] C. Wang,et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China , 2020, Annals of Oncology.
[23] W. Gong,et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.
[24] G. Lippi,et al. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19) , 2020, Respiratory Medicine.
[25] G. Onder,et al. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.
[26] Lei Dong,et al. Kidney disease is associated with in-hospital death of patients with COVID-19 , 2020, Kidney International.
[27] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.
[28] Rui Ji,et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis , 2020, International Journal of Infectious Diseases.
[29] Wei Wang,et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.
[30] C. Akdis,et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.
[31] Ruchong Chen,et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China , 2020, The Lancet Oncology.
[32] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[33] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[34] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[35] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[36] J. Ryu,et al. The Role of Infection in Interstitial Lung Diseases , 2017, Chest.
[37] D. Weiskopf,et al. The aging of the immune system , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[38] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China./ 新型冠状病毒肺炎流行病学特征分析 , 2020 .